Current roles
From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.
Past roles
“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.
Sits alongside
People who currently share a board or management team with this person.
- Alecia A. DecoudreauxCVS
- Amy Compton-PhillipsCVS
- Anne A. FinucaneCVS
- Brian NewmanCVS
- C. David Brown IICVS
- Douglas H. ShulmanCVS
- Fernando AguirreCVS
- Guy P. SansoneCVS
- Heidi B. CapozziCVS
- James David ClarkCVS
- J. David JoynerCVS
- Jeffrey R. BalserCVS
- John E. GallinaCVS
- J. Scott KirbyCVS
- Leslie Norwalk VCVS
- Michael F. MahoneyCVS
- Prem S. ShahCVS
- Roger N. FarahCVS
- Samrat S. KhichiCVS
- Steven H. NelsonCVS
- Tilak MandadiCVS
Open-market trades
Purchases and sales reported on Form 4 at S&P 500 companies.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 21, 2026 | CVS | Sale | 370,462 | $93.45 | $34.6M |
| May 20, 2026 | CVS | Sale | 66,881 | $95.67 | $6.4M |
| May 20, 2026 | CVS | Sale | 800 | $96.28 | $77K |
| May 20, 2026 | CVS | Sale | 797,628 | $93.48 | $74.6M |
| May 20, 2026 | CVS | Sale | 152,691 | $94.81 | $14.5M |
| May 19, 2026 | CVS | Sale | 1,983,387 | $94.45 | $187.3M |
| May 19, 2026 | CVS | Sale | 151 | $95.18 | $14K |
| May 6, 2025 | CVS | Sale | 150,000 | $66.67 | $10.0M |
| May 5, 2025 | CVS | Sale | 96,999 | $67.99 | $6.6M |
| May 5, 2025 | CVS | Sale | 1,226,933 | $67.37 | $82.7M |
| May 2, 2025 | CVS | Sale | 222,556 | $68.38 | $15.2M |
| May 2, 2025 | CVS | Sale | 1,679,736 | $67.39 | $113.2M |
| May 2, 2025 | CVS | Sale | 373,776 | $69.66 | $26.0M |
SEC reporting-owner ID (CIK) 1228603 · all filings on EDGAR